Quick Answer
HUTCHMED (China) Ltd reported Research And Development Expense of $148.30 million for the year ending 2025.
- HUTCHMED (China) Ltd showed a decrease of -30.1% in Research And Development Expense from 2024 to 2025.
- This data is from HUTCHMED (China) Ltd's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), HUTCHMED (China) Ltd's Research And Development Expense has grown by 395.7%.
- Historical annual values: Fiscal year 2025: $148.30 million | Fiscal year 2024: $212.11 million | Fiscal year 2023: $302.00 million | Fiscal year 2022: $386.89 million | Fiscal year 2021: $299.09 million | Fiscal year 2020: $174.78 million | Fiscal year 2019: $138.19 million | Fiscal year 2018: $114.16 million | Fiscal year 2017: $75.52 million | Fiscal year 2016: $66.87 million | Fiscal year 2015: $47.37 million | Fiscal year 2014: $29.91 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: